Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
Clinical trial NCT03104595 · COMPLETED
Trial details
- NCT number
- NCT03104595
- Sponsor
- Enzychem Lifesciences Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-30
- Primary completion
- 2019-11-26
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.